Medically reviewed by Michael MacIntyre, MDSchizophrenia medication falls under two main categories: older, first-generation, ...

In the carefully monitored confines of a clinical facility, patients with schizophrenia took what looked like an ordinary ...

In a Phase III clinical trial conducted by MIT spinout Lyndra Therapeutics, the researchers used the once-a-week pill to deliver a widely used medication for managing the symptoms of schizophrenia ...

Synapse-restoring pill set for human trials as novel schizophrenia treatment A once-a-day pill that regenerates lost nerve cell connections is being trialed as a schizophrenia treatment DALL-E ...

Supplements that may improve symptoms of schizophrenia and its treatment include omega-3 fatty acids, B vitamins, vitamin E, zinc, magnesium, and N-acetylcysteine.

For the first time in decades, the Food and Drug Administration has approved a new type of drug for schizophrenia. The twice-a-day pill to be marketed by Bristol Myers Squibb will be called ...

In several studies, only 40% to 60% of people with schizophrenia stay on track with their daily meds. Long-acting drugs solve the problem of having to take medicine every day.

A Phase 3 clinical trial of a new once-weekly risperidone pill for schizophrenia shows it delivers comparable therapeutic effects to daily treatment, offering improved convenience and potential ...

For the first time in decades, the Food and Drug Administration has approved a new type of drug for schizophrenia. The twice-a-day pill to be marketed by Bristol Myers Squibb will be called ...

About 3.7 million, or 1.8%, of adults in the U.S. have a lifetime history of schizophrenia, according to research published in 2023. The estimate was two to three times higher than previous estimates.

WEDNESDAY, Nov. 13, 2024 (HealthDay News) -- People are at higher risk of schizophrenia if they indulge in psychedelic drugs, a new study warns.

MIT researchers developed a pill that can be taken once a week instead of daily, gradually releasing medication from within the stomach. In a phase 3 clinical trial, the treatment maintained ...